Research results confirm the'power' of a vaccine to prevent COVID-19 in Italy.
Italy's Ferrara University, along with local health authorities in Pescara, central Abruzzo, analyzed 37,000 residents who received the vaccine from January to the end of last month. As a result, the number of confirmed cases was 95% and the number of severely ill patients compared to the non-vaccinated control group. Was found to be 99% less, respectively, La Repubblica daily reported on the 14th (local time).
One 95-year-old woman died after being vaccinated during that period.
He was known to have had a serious illness even before he was vaccinated.
As in the UK and Israel, the numbers proved that the vaccine had a great effect in blocking the spread of Corona 19.
This is the first time that a vaccine has been validated on such a relatively large scale in Italy.
Lamberto Manzoli, a professor of epidemiology at the University of Ferrara, who participated as a research team, welcomed "good results beyond expectations."
Professor Manzoli said, "The AstraZeneca (AZ) vaccine showed efficacy with just one dose, and the late-supplied Pfizer and Modena also proved their ability to block infections and severe patients. There is no doubt about the efficacy of the vaccine. "He emphasized.
In the case of the AZ vaccine, there is also analysis data showing a 95% reduction in mortality even with a single dose.
Prof. Manzoli, who is confident in the formation of population immunity through vaccines, predicts, "In the summer, seasonal effects are likely to weaken the prevalence of the virus, and from September the number of confirmed cases and deaths will be markedly reduced."
Italy launched its vaccination campaign on December 27 last year, and so far, more than 1,8185,000 people have been vaccinated at least once.
It is about 30% of the total population (about 60 million)
The number of people who completed the second vaccination was estimated to be 8,163 thousand, 13.6% of the total population.
(Photo = Yonhap News)